MOUNTAIN VIEW, CA, September 5, 2024 – Today, National Cellulitis Day, Revelle Aestheticsa VC-backed Silicon Valley FemTech company, launched The Naked Truth About Cellulite™ campaign to debunk myths about cellulite, a common skin condition that affects up to 90% of women;2 However, only 7% know what mainly causes cellulite.3 The campaign further aims to empower women to stop wasting time and money on ineffective treatments that do not work and to speak to medical aesthetics provider for a real solution to unwanted cellulite.
The campaign addresses the results of a comprehensive survey of more than 1,500 women aged 18 and over with cellulite on the thighs and buttocks, and debunks misconceptions about cellulite, including that it is mainly caused by poor diet and lack of exercise. Additionally, the survey found that nearly 80% of women say creams and gadgets don’t work long-term, sending a wake-up call to the $3 billion annual market for topical cellulite treatment.4
The campaign also features success stories from real women – including Angela B. (50), Valerie K. (42), Diana W. (36) and Erika G. (35) – who chose Revelle’s groundbreaking Avéli® cellulite treatment, an in- FDA-approved office product that targets the root cause of cellulite, specifically the stiff, hard, fibrous bands that pull on the skin. Avéli® is clinically proven to release cellulite-causing bands in one treatment, providing fast, long-lasting results.5,6 Avéli® is now available in over 700 beauty practices nationwide and has a RealSelf “worth it” rating of 92%.7 Avéli® also won the prestigious 2024 NewBeauty “Best Minimally Invasive Treatment of Cellulitis” Award for the second consecutive year.
“National Cellulite Day is about celebrating women who feel confident, glowing and free in their bodies with and without cellulite,” said Caroline Van Hove, President and CEO of Revelle Aesthetics. “The results of our nationwide survey show that hundreds of women are unnecessarily spending thousands of dollars on creams and gadgets that don’t deliver the results they promise. Our goal is to provide women with literally the naked truth about what causes cellulite, because they should feel feel comfortable talking about it with their providers if it affects them negatively and how Avéli® is delivering on its promise.”
The Naked Truth About Cellulite™ Omnibus survey results1
A comprehensive survey was carried out between 20 and 26 August 2024 of 2,515 women aged 18+, with 62% (1,565) admitting to having cellulite on their thighs and buttocks and almost a third having bought creams, lotions or gadgets to try get rid of it. Statistically significant findings reveal the following:
- Cellulite affects everyday life, including women’s clothing, with 61% avoiding wearing shorts, swimwear or light-colored leggings because of their cellulite
- More than 6 in 10 (62%) believe the myth that lifestyle choices, such as poor diet and lack of exercise, mainly cause cellulite, leading to women unnecessarily blaming themselves for the skin condition.
- 90% of women who have bought creams, lotions and gadgets to try to get rid of their cellulite have spent up to $1,000 looking for a solution
- Almost 80% of women who have bought creams, lotions and gadgets to try to get rid of cellulite say they don’t work long term
These data support the need for The Naked Truth About Cellulite™ campaign, which includes educational materials and social/digital ads encouraging women with unwanted cellulite to ditch creams and gadgets that don’t deliver the results they promise TheNakedTruthAboutCellulite.com to learn about the root cause of cellulite, hear patient success stories, find an Avéli® provider and receive a $250 e-Gift Card for an Avéli® treatment completed between September 5 and October 31, 2024.
“This bold campaign is exciting because it exposes the myths that keep women from knowing the root cause of cellulite, why creams and gadgets will never work, and why Avéli® is a breakthrough treatment option,” said Dr. Ashley Amalfi, Head of Council. -board-certified plastic surgeon, fellow at the Quatela Center for Plastic Surgery in Rochester, New York, and President of the Women in Plastic Surgery Forum. “As an Avéli® provider and satisfied Avéli® patient, I know firsthand how this one-time, in-office treatment delivers fast, real results that last,6 with little to no downtime.”
FOR CELLULITE AND AVÉLI®
Cellulite is a common skin condition that affects up to 90% of women of different weights, body types, fitness levels and diets.2 It is an anatomical condition under the skin that occurs when stiff, hard, fibrous bands between the skin and muscles pull on the skin to create dents, fissures, and dimples.5 Therefore, it cannot be solved by topical treatments, yet $3 billion is spent every year on cellulite creams and gadgets3 which do not work.
Women with unwanted cellulite report that their lives are negatively affected, including feeling self-conscious, insecure, frustrated, ashamed, and too embarrassed to talk to the cosmetic provider about unwanted cellulite.8 Avéli® was developed to help reduce the physical and mental effects that cellulite can have on women and ultimately deliver the meaningful results women desire. It is the first and only cellulite device that allows a provider to locate and release the key underlying cause of cellulite – stiff, hard, fibrous bands that pull on the skin (diaphragmatic bands) – and confirm release in real time. Avéli® is a minimally invasive treatment that has been clinically proven in a 12-month observational study to provide lasting reduction of cellulite on the buttocks and thighs in a single, in-office procedure that takes approximately one hour with local numbing and minimal to no downtime. .
Avéli® provider cosmetic surgeon and dermatologist Mary-Margaret Kober, MD, FAAD, at Denver-based Jack Zamora MD Cosmetic Surgery and Aesthetics, said, “I have treated women with Avéli® both as a stand-alone treatment for cellulite and As part of their lower body rejuvenation journey Not only were they happy with their results, but many are celebrating the one and two year anniversary of Avéli®, I am delighted that this campaign features success stories from women Avéli® and that it gives empowering women to learn the truth about what causes cellulite and how to effectively treat it.”
ABOUT AESTHETIC REVELLE
Revelle Aesthetics is a Silicon Valley-based FemTech company focused on innovating smart solutions that address the root causes of women’s most vexing aesthetic concerns. The company is committed to developing precision technologies that deliver meaningful results for women and reliable results for doctors. Revelle Aesthetics’ first device, Avéli®, has been cleared by the FDA for long-term reduction of the appearance of cellulite on the buttocks and thighs of adult females, as supported by clinical data demonstrating treatment benefits through one-year follow-up. Founded in 2018 and based in Mountain View, California, Revelle Aesthetics is a privately held company backed by leading venture capital firms New Enterprise Associates and KCK Medtech. For more information, visit www.RevelleAesthetics.com.
Media contact:
Susan Huber
[email protected]917-531-6953
References
1 Full Omnibus Survey, conducted by YouGov on behalf of Avéli®, available on request. The total sample size was 4,901 adults, of whom 2,515 were women and 1,565 were women with lower body cellulite. The fieldwork took place between August 20 and 26, 2024. The survey was conducted online. Figures are weighted and representative of all US adults (age 18+).
2 Emanuele E. Cellulitis: advances in treatment: facts and controversies. Clin Dermatol. 2013? 31 (6): 725-30.
3 Data on file, Revelle Aesthetics, Inc.
4
5 Stevens WG, et al. Aesthet Surg J. 2022;42(8):937-945.
6 Stevens WG, et al. Aesthet Surg J. 2023;43(4):455-466.
7 Get RealSelf.com Score 8.27.24.
8 Data on file, Revelle Aesthetics, Inc.
